• 로그인 / 등록
  • Language
    • English
    • Deutsch
    • Française
    • Español
    • Português
    • Italia
    • Русский
    • 日本語
    • 한국어
    • 简体中文
    • 繁體中文

One of the five core technical staff, Dr. Wu Jingang, resigned. SMIC stated that it did not adversely affect the overall R&D strength.

  • 출시일:2021-07-05 10:20:31
  • 출처:CMS
  • 클릭 볼륨:348

On the evening of July 4, SMIC issued an announcement stating that Dr. Wu Jingang, the company's core technical staff, had recently applied for resignation due to personal reasons and completed the resignation procedures. After resignation, Dr. Wu Jingang no longer holds any position in the company. At present, the company's technology research and development work is proceeding normally, and the resignation of Dr. Wu Jingang has not had a significant adverse effect on the company's overall research and development strength.

1.png

The previous prospectus also showed that Dr. Wu Jingang is one of the only five core technical personnel of SMIC. The remaining four are: Zhao Haijun, co-CEO of SMIC, co-CEO Liang Mengsong, and executive vice president of technology research and development. Zhou Meisheng and Zhang Xin, senior vice president of operations and engineering. According to the disclosed information, he is 54 years old this year, Chinese nationality, and joined SMIC in 2001. During his tenure, he was responsible for participating in the research and development and management of the company's FinFET advanced process technology.

According to the new equity incentive plan, 90% of the first-phase grants will be vested in installments within five years from the date of the first grant. In the first phase of the award list, Dr. Wu Jingang, as one of the core technical personnel of SMIC, obtained 160,000 restricted stocks of the company, accounting for 0.21% of the total number of restricted stocks granted.

The first award price of this incentive plan is determined based on 36.46% of the average trading price of 54.86 yuan of the company's A shares on the trading day before the announcement of this plan, which is 20 yuan per share. This means that the restricted stock that Dr. Wu Jingang will obtain corresponds to the market value of SMIC's stock at that time of 8.78 million yuan.

If calculated on the basis of the closing price of SMIC Science and Technology Innovation Board stocks as of Friday, July 2, 58.13 yuan per share, the corresponding market value of these 160,000 restricted stocks is approximately 9.3 million yuan.

According to the equity incentive plan, if the incentive object resigns, the restricted stock that has been granted but not vested by the incentive object from the date of resignation shall not be vested, and shall become invalid. Therefore, the resignation of Dr. Wu Jingang means that he voluntarily gave up these 160,000 restricted shares.


Regarding Wu Jingang’s resignation, SMIC stated that the company’s technical R&D work is currently proceeding normally, and Dr. Wu’s resignation did not have a significant adverse effect on the company’s overall R&D strength. Through long-term technology accumulation and development, the company has established a complete R&D system. The company always attaches importance to the training and construction of talent teams, and the training and selection of potential employees, forming an ever-expanding excellent R&D team and a deep talent reserve. Have the talent base to maintain technological advancement and continuous innovation. In 2018, 2019 and 2020, the number of R&D personnel of the company was 2,096, 2,530 and 2,335, accounting for 11.86%, 16.02% and 13.50% of the total number of employees, respectively. The number of R&D personnel remained stable.

From the perspective of stock price performance, due to the resignation of core technical personnel, SMIC dropped by nearly 1 point at the opening.


귀하의 위치를 ​​선택하십시오